13F Holdings
中文EN

LYB LyondellBasell Industries N.V.

Industrial Organic Chemicals · NYSE · SEC CIK 1489393 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.5%
TTM net income YoY208.4%
TTM EPS YoY206.1%
Revenue 3-yr CAGR-8.2%
Net income 3-yr CAGR-17.1%

Margins

Gross margin14.3%
Operating margin8.6%
Net margin4.1%
FCF margin7.6%
EBITDA margin13.2%

Returns

ROE11.9%
ROA3.8%
ROIC (approx.)10.8%
Asset turnover0.93x

Leverage & solvency

Liabilities / assets67.3%
Debt / equity1.02x
Current ratio1.78x
Interest coverage5.06x

Cash quality & payout

Operating cash flow / net income2.85x
Accruals ratio-7.0%
Payout ratio85.6%
Capex / revenue4.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31FY2023*2023-12-31FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue$30.15B$33.39B$33.34B$50.45B$46.17B
Cost of revenue$27.58B$28.75B$28.43B$43.85B$37.40B
Gross profit$2.58B$4.64B$4.90B$6.60B$8.78B
R&D expense$136.00M$135.00M$130.00M$124.00M$124.00M
SG&A expense$1.61B$1.64B$1.54B$1.31B$1.25B
Operating income-$420.00M$1.92B$2.73B$5.10B$6.77B
Interest expense$487.00M$481.00M$477.00M$287.00M$519.00M
Pretax income-$715.00M$1.70B$2.30B$4.78B$6.79B
Income tax$70.00M$259.00M$433.00M$882.00M$1.16B
Net income-$738.00M$1.37B$2.12B$3.89B$5.62B
EBITDA$970.00M$3.44B$4.26B$6.37B$8.17B
EPS (basic)-2.344.166.4811.8416.77
EPS (diluted)-2.344.156.4611.8116.75
Dividends declared per share5.455.274.944.704.44
Balance sheet
Cash & equivalents$3.44B$3.39B$3.40B$2.16B$1.48B
Short-term investments$2.03B$2.61B$2.43B$1.19B$9.00M
Receivables———$3.39B$4.57B
Inventory$3.53B$4.66B$4.76B$4.80B$4.90B
Current assets$10.87B$12.27B$13.15B$11.85B$12.22B
PP&E, net$15.83B$15.07B$15.55B$15.39B$14.56B
Goodwill$708.00M$1.56B$1.65B$1.83B$1.88B
Intangibles$450.00M$577.00M$641.00M$662.00M$695.00M
Total assets$34.00B$35.75B$37.00B$36.37B$36.74B
Current liabilities$6.13B$6.71B$7.15B$6.76B$7.23B
Short-term debt$226.00M$119.00M$117.00M$349.00M$362.00M
Long-term debt$12.12B$10.53B$10.33B$10.54B$11.25B
Total debt$12.35B$10.65B$10.45B$10.89B$11.61B
Total liabilities$23.80B$23.16B$23.94B$23.62B$24.75B
Shareholders' equity$10.08B$12.46B$12.93B$12.62B$11.86B
Net debt$8.91B$7.26B$7.04B$8.73B$10.13B
Shares outstanding322.08M323.89M324.48M325.72M329.54M
Cash flow statement
Operating cash flow$2.26B$3.82B$4.94B$6.12B$7.70B
Capital expenditure$1.88B$1.84B$1.53B$1.89B$1.96B
Free cash flow$384.00M$1.98B$3.41B$4.23B$5.74B
Investing cash flow-$1.78B-$1.85B-$1.78B-$1.98B-$1.50B
Financing cash flow-$507.00M-$1.90B-$1.95B-$3.41B-$6.38B
Depreciation & amortization$1.39B$1.52B$1.53B$1.27B$1.39B
Stock-based compensation$91.00M$91.00M$91.00M$70.00M$66.00M
Dividends paid$1.76B$1.72B$1.61B$3.25B$1.49B
Share buybacks$201.00M$195.00M$211.00M$420.00M$463.00M

Free plan shows the latest 5 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.